Based on historical data, attachment loss improved by 2.0 mm 6 months after surgery alone, while improvement reached 3.4 mm following DPSC injection, with a standard deviation of 1.7 mm
Key Facts & Research Milestones: GHK-Cu Timeline GHK-Cu in the Context of Broader Longevity Research GHK-Cu does not exist in isolation within the peptide research landscape
Visible improvement may take 4-12 weeks, depending on the severity of pigmentation and consistency of use
A comprehensive 2024 review of 36 studies (1993-2024) confirms BPC-157 promotes healing through growth factor upregulation, VEGF/VEGFR2 expression modulation, and NO system regulation
It is not approved for human or veterinary use, clinical administration, therapeutic intervention, or diagnostic procedures
Without adequate copper at the site of collagen assembly, the body produces weak, poorly cross-linked collagen even if production volume is high